Analytical Data
-
Gene name
TCTA
- Application
-
Alternative Names
T-cell leukemia translocation altered gene; T-cell leukemia translocation-altered gene Protein; T-cell leukemia translocation-associated gene Protein; Tcta; TCTA_HUMAN
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P57738
-
Expression Region
1-103 aa
-
AA Sequence
MAESWSGQALQALPATVLGALGSEFLREWEAQDMRVTLFKLLLLWLVLSLLGIQLAWGFY GNTVTGLYHRPGLGGQNGSTPDGSTHFPSWEMAANEPLKTHRE
-
Molecular Weight
11.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCTA, or Transcriptional Co-Activator with PDZ-Motif, is a protein that plays a crucial role in various cellular processes, including transcription regulation, cell signaling, and the maintenance of stem cell pluripotency. Research on TCTA is driven by its involvement in numerous physiological and pathological conditions, such as cancer, where its dysregulation may contribute to tumor progression and metastasis. In recent years, scientists have focused on the biochemical characterization and functional analysis of TCTA to understand its mechanisms of action and interaction pathways within the cell. The recombinant production of TCTA has become a valuable tool for studying its properties and potential as a therapeutic target. By using techniques like recombinant DNA technology, researchers can produce large quantities of TCTA, allowing for in-depth investigations into its structure-function relationships and interactions with other proteins. The insights gained from these studies may not only illuminate the biological significance of TCTA but also pave the way for the development of novel strategies in cancer therapy and regenerative medicine. Understanding TCTA’s role in cellular processes can provide foundational knowledge that bridges gaps in our comprehension of how transcriptional regulation impacts human health and disease. Overall, the research into TCTA and its recombinant protein forms represents a promising frontier in molecular biology and therapeutic development.
